Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Common Equity (2016 - 2025)

Qiagen's Common Equity history spans 15 years, with the latest figure at $3.6 billion for Q4 2024.

  • For Q4 2024, Common Equity changed N/A year-over-year to $3.6 billion; the TTM value through Dec 2024 reached $3.6 billion, changed N/A, while the annual FY2024 figure was $3.6 billion, N/A changed from the prior year.
  • Common Equity for Q4 2024 was $3.6 billion at Qiagen, up from $3.5 billion in the prior quarter.
  • Across five years, Common Equity topped out at $3.6 billion in Q4 2024 and bottomed at $2.8 billion in Q4 2020.
  • The 4-year median for Common Equity is $3.3 billion (2021), against an average of $3.2 billion.
  • The largest annual shift saw Common Equity grew 10.3% in 2020 before it grew 11.95% in 2022.
  • A 4-year view of Common Equity shows it stood at $2.8 billion in 2020, then rose by 10.68% to $3.1 billion in 2021, then rose by 11.95% to $3.5 billion in 2022, then grew by 2.91% to $3.6 billion in 2024.
  • Per Business Quant, the three most recent readings for QGEN's Common Equity are $3.6 billion (Q4 2024), $3.5 billion (Q4 2022), and $3.1 billion (Q4 2021).